Increased Energy Expenditure: Activation of the glucagon receptor encourages the body to break down stored fat and increases the metabolic rate, further supporting weight loss
A Research Guide Retatrutide is the triple incretin agonist defining the next generation of metabolic peptide research
Cersosimo E, Triplitt C, Solis-Herrera C, Mandarino LJ, DeFronzo RA
Instead of targeting a single receptor, retatrutide activates three hormone receptors involved in appetite and metabolism: GLP-1 receptor GIP receptor Glucagon receptor Because it activates all three pathways, it is often called a triple agonist
It is important to note that whilst constipation is common, it does not affect all patients, and individual responses vary considerably
Seek urgent care for chest pain, fainting, or severe allergic reactions